Yanli Luo

1.5k total citations
72 papers, 1.1k citations indexed

About

Yanli Luo is a scholar working on Psychiatry and Mental health, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Yanli Luo has authored 72 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 14 papers in Molecular Biology and 12 papers in Cognitive Neuroscience. Recurrent topics in Yanli Luo's work include Psychosomatic Disorders and Their Treatments (10 papers), Functional Brain Connectivity Studies (6 papers) and Adsorption and biosorption for pollutant removal (6 papers). Yanli Luo is often cited by papers focused on Psychosomatic Disorders and Their Treatments (10 papers), Functional Brain Connectivity Studies (6 papers) and Adsorption and biosorption for pollutant removal (6 papers). Yanli Luo collaborates with scholars based in China, United States and Australia. Yanli Luo's co-authors include Xiaotian Zhao, Xiaoshuang Guo, Jianjun Chen, Yuan Cheng, Weien Yuan, Xiao Huang, JI Jian-lin, Chao Yan, Zhiyong Zhao and Wanjun Luo and has published in prestigious journals such as PLoS ONE, Current Biology and Journal of Medicinal Chemistry.

In The Last Decade

Yanli Luo

67 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanli Luo China 16 300 227 167 153 120 72 1.1k
Yan Jiang China 24 620 2.1× 307 1.4× 352 2.1× 95 0.6× 83 0.7× 93 1.7k
Bing Xue China 26 569 1.9× 185 0.8× 230 1.4× 99 0.6× 25 0.2× 79 1.9k
Wei‐Wen Lin Taiwan 20 277 0.9× 150 0.7× 51 0.3× 73 0.5× 227 1.9× 54 1.1k
Yuan Peng China 17 234 0.8× 333 1.5× 136 0.8× 69 0.5× 34 0.3× 39 813
Zhenguo Liu China 23 289 1.0× 128 0.6× 120 0.7× 47 0.3× 62 0.5× 78 1.3k
Ying Qian China 20 270 0.9× 87 0.4× 71 0.4× 50 0.3× 249 2.1× 84 1.4k
Qing Xin China 21 326 1.1× 197 0.9× 55 0.3× 81 0.5× 36 0.3× 77 1.2k

Countries citing papers authored by Yanli Luo

Since Specialization
Citations

This map shows the geographic impact of Yanli Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanli Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanli Luo more than expected).

Fields of papers citing papers by Yanli Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanli Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanli Luo. The network helps show where Yanli Luo may publish in the future.

Co-authorship network of co-authors of Yanli Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Yanli Luo. A scholar is included among the top collaborators of Yanli Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanli Luo. Yanli Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Luo, Yanli, et al.. (2025). m6A demethylase FTO/ALKBH5 promotes diabetes-induced endothelial cell dysfunction by negatively regulating lncRNA H19. Experimental and Molecular Pathology. 143. 104970–104970. 1 indexed citations
3.
Zhang, Xueyan, et al.. (2025). Trichoderma brevicompactum 6311: Prevention and Control of Phytophthora capsici and Its Growth-Promoting Effect. Journal of Fungi. 11(2). 105–105. 2 indexed citations
4.
5.
Chen, Danyang, Yuzhuo Zhang, Wanying Dong, et al.. (2024). A noradrenergic pathway for the induction of pain by sleep loss. Current Biology. 34(12). 2644–2656.e7. 5 indexed citations
6.
Luo, Yanli, Chengbin Liu, Xianli Wang, et al.. (2024). A novel, low-cost, and efficient separation strategy based on S-doped C3N4 for the analysis of PCDD/Fs and dioxin-like PCBs. Journal of environmental chemical engineering. 12(3). 112529–112529. 2 indexed citations
7.
Li, Xianzhen, et al.. (2024). Silica–magnesium coupling in lignin–based biochar: A promising remediation for composite heavy metal pollution in environment. Journal of Environmental Management. 363. 121392–121392. 12 indexed citations
8.
Zhou, Yong, YanYan Wei, Lihua Xu, et al.. (2024). Distribution of self-reported borderline personality disorder traits symptoms in a large-scale clinical population. Frontiers in Psychiatry. 15. 1424966–1424966. 1 indexed citations
9.
Yang, Jianying, et al.. (2023). A Multi-Period Model of Compressor Scheme Optimization for the Shale Gas Gathering and Transportation System. Processes. 11(11). 3101–3101. 1 indexed citations
10.
Yuan, Jing, Feng Gao, Yanli Luo, et al.. (2023). Pioneering 4,11-Dioxo-4,11-dihydro-1H-anthra[2,3-d]imidazol-3-ium Compounds as Promising Survivin Inhibitors by Targeting ILF3/NF110 for Cancer Therapy. Journal of Medicinal Chemistry. 66(24). 16843–16868. 6 indexed citations
11.
Yang, Lingling, et al.. (2023). Co-deposition and thermal conductivity of nickel–graphene composite coatings on copper surface. Applied Physics A. 129(11). 5 indexed citations
12.
Zhou, Qian, Xia Sun, Weina Ding, et al.. (2021). Decline of anterior cingulate functional network efficiency in first-episode, medication-naïve somatic symptom disorder and its relationship with catastrophizing. Journal of Psychiatric Research. 140. 468–473. 10 indexed citations
13.
Luo, Yanli, Jin Huang, Tingting Yang, et al.. (2021). Role of PRPS2 as a prognostic and therapeutic target in osteosarcoma. Journal of Clinical Pathology. 74(5). 321–326. 2 indexed citations
14.
Li, Jie, Zilong Gao, Yifan Feng, et al.. (2020). SNRIs achieve faster antidepressant effects than SSRIs by elevating the concentrations of dopamine in the forebrain. Neuropharmacology. 177. 108237–108237. 36 indexed citations
15.
16.
Zhao, Zhiyong, Chaozheng Tang, Chao Yan, et al.. (2017). Altered resting-state intra- and inter- network functional connectivity in patients with persistent somatoform pain disorder. PLoS ONE. 12(4). e0176494–e0176494. 84 indexed citations
17.
Luo, Yanli, et al.. (2013). Novel prognostic markers for patients with triple-negative breast cancer. Human Pathology. 44(10). 2180–2187. 45 indexed citations
18.
Luo, Yanli. (2012). Survey on the Awareness of Knowledge about Intravenous Infusion in Clinical Nurses. Huaxi yixue. 1 indexed citations
19.
Luo, Yanli. (2010). Relationship between symptom experiences and quality of life in liver transplant recipients. Zhonghua huli zazhi. 1 indexed citations
20.
Luo, Yanli, Wenyuan Wu, Chunbo Li, & Jun Yao. (2009). Cost-effectiveness analysis of fluoxetine for patients with persistent somatoform pain disorder. Chin J Psychiatry. 42(2). 71–74. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yan Jiang Breakdown of academic impact, for papers by Bing Xue Breakdown of academic impact, for papers by Wei‐Wen Lin Breakdown of academic impact, for papers by Yuan Peng Breakdown of academic impact, for papers by Zhenguo Liu Breakdown of academic impact, for papers by Ying Qian Breakdown of academic impact, for papers by Qing Xin
Rankless by CCL
2026